The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.


By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2
https://ift.tt/cHEVJZ2
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)